| |
||||||
Company |
Date Filed |
Date Comm. |
Shares/Units (M) |
Price |
Gross (M) |
|
| Bone Care International Inc. (BCII) |
9/12 |
12/11 |
2.3S |
$16 |
$36.8 |
|
| ICOS Corp. (ICOS) |
10/11 |
12/14 |
5.175S |
$37 |
$191.48 |
|
Neurocrine Biosciences Inc. (NBIX) |
10/4 |
12/6 |
3S |
$30 |
$90 |
|
| North American Scientific Inc. (NASI) |
N/A |
12/20 |
2.695 |
$17.875 |
$48.2 |
|
Oxford Glycosciences plc (UK; OGSI; LSE:OGS) |
11/13 |
12/7 |
11.77S |
12.75 (US$18.36) |
150 (US$216) |
|
| |
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| ArQule Inc. (ARQL) | 10/20 | 11/21 | 3.36S | $22.50 | $75.6 |
|
| Avigen Inc. (AVGN; shelf registration) | 10/10 | 11/2 | 1.66S | $37.50 | $62.3 |
|
| Avigen Inc. (AVGN; shelf registration) | 10/10 | 11/15 | 0.694S | $45.06 | $31.3 |
|
| CIMA Labs (CIMA) | 10/6 | 11/2 | 3.2S | $50 | $160 |
|
| Corvas International Inc. (CVAS) | 9/29 | 11/8 | 5.75S | $20 | $115 |
|
| CuraGen Corp. (CRGN) | 11/6 | 11/16 | 4.8S | $41 | $196.8 |
|
| IDEC Pharmaceuticals (IDPH) | 11/3 | 11/16 | 2.6S | $181.81 | $427.7 |
|
| Immunex Corp. (IMNX) | 10/18 | 11/10 | 20S | $39.75 | $795 |
|
| ImmunoGen Inc. (IMGN) | 10/17 | 11/16 | 4S | 34.4 | $121.5 |
|
| NPS Pharmaceuticals Inc. (NPSP) | 10/13 | 11/10 | 4.6S | $42 | $193.2 |
|
| OSI Pharmaceuticals Inc. (OSIP) | 9/29 | 11/1 | 6.16S | $70 | $430.7 |
|
| Ribozyme Pharmaceuticals Inc. (RZYM; shelf registration) | 10/6 | 11/6 | 3S | $22.20 | $66.6 |
|
| |
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| Albany Molecular Research Inc. (AMRI) | 9/6 | 10/6 | 3.615S | $42.25 | $152.8 |
|
| Alexion Pharmaceuticals Inc. (ALXN; shelf registration) | 10/6 | 10/27 | 2.3S | $90.87 | $209 |
|
| Dendreon Corp. (DNDN) | 10/11 | 10/27 | 2.5S | $15.625 | $39.1 |
|
| Human Genome Sciences Inc. (HGSI) | 9/6 | 10/27 | 12.7S | $75 | $952.5 |
|
| Immunex Corp. (IMNX) | 8/9 | 10/18 | 20S | $46.19 | $923.8 |
|
| Insmed Inc. (INSM) | 9/26 | 10/27 | 6.475S | $11.875 | $76.89 |
|
| Millennium Pharmaceuticals Inc. (MLNM) | 8/1 | 10/6 | 11S | $64 | $704 |
|
| Onyx Pharmaceuticals Inc. (ONXX) | 9/22 | 10/13 | 3.45S | $15 | $51.8 |
|
| StressGen Biotechnologies Corp. (Canada; TSE:SSB) | 9/19 | 10/17 | 6.5S | C$7 (US$4.61) | C$45.5 (US$29.9) |
|
| |
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| Cell Therapeutics Inc. (CTIC) | 7/13 | 9/18 | 3.6S | $38 | $136.8 |
|
| NeoPharm Inc. (NEOL) | 8/24 | 9/25 | 3S | $35.50 | $106.5 |
|
| Protein Design Labs Inc. (PDLI) | 8/29 | 9/29 | 3S | $118.44 | $355.3 |
|
| |
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| AltaRex Corp. (TSE:AXO) | 5/4 | 8/9 | 9.2S | C$0.85 | C$7.8 (US$11.5) |
|
| The Immune Response Corp. (IMNR) | 7/19/99 | 8/11 | 2.76 | $6 | $16.56 |
|
|
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| AVI BioPharma Inc. (AVII) | 6/16 | 7/27 | 3S | $7.25 | $21.75 |
|
| Genome Therapeutics Corp. (GENE) | 3/16 | 7/10 | 1.5S | $31.01 | $44.7 |
|
| Zeltia (Spain) | N/A | 7/6 | 3S | $57.64 | $172.5 |
|
|
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| Aviron (AVIR; shelf registration) | 9/16 | 6/12 | 0.34S | $23.53 | $8 |
|
| EntreMed Inc. (ENMD; shelf registration) | 1/14 | 6/14 | 1S | $22 | $22 |
|
| SignalGene (Canada; TSE:SGI) | 5/19 | 6/14 | 12.5 | C$1.55 (US$1.05) | C$21.5 (US$14.5) |
|
|
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| Aviron (AVIR) | 3/8 | 5/12 | .35S | $22.92 | $8 |
|
| Karo Bio AB (Sweden; Stockholm:KARO) | N/A | 5/18 | 0.6S | 336 SEK (US$36.69) | 201.6 SEK (US$22.0) |
|
| Lorus Therapeutics Inc. (OTC BB:LORFF) | 4/12 | 5/2 | 15.3S | C$3 | C$46 (US$31) |
|
| Theratechnologies (TSE:TH) | 4/26 | 5/11 | 2.45S | C$8.60 | C$24.2 (US$16.4) |
|
| Vion Pharmaceuticals Inc. (VION) | 3/10 | 5/11 | 2.6W | - | $15.8 |
|
|
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| Avigen Inc. (AVGN) | 2/18 | 4/13 | 1S | $26 | $26.0 |
|
| Aviron (AVIR) | 3/8 | 4/4 | 2S | $22.50 | $45 |
|
| Cambridge Antibody Technology plc (LSE:CAT) | 3/7 | 4/3 | 4.86 | 18.50 (US$29.11) | 90.0 (US$141.6) |
|
| Corixa Corp. (CRXA) | 3/7 | 4/7 | 1.9S | $32 | $60.8 |
|
| Cubist Pharmaceuticals (CBST) | 3/10 | 4/6 | 2.875S | $33 | $94.9 |
|
| Ribozyme Pharmaceuticals Inc. | 3/2 | 4/6 | 3.15S | $18 | $56.7 |
|
| Texas Biotechnology Corp. (AMEX:TXB) | 3/8 | 4/6 | 5S | $12.50 | $62.5 |
|
|
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| Angiotech Pharmaceuticals Inc. (Canada; ANPI; TSE: ANP) | 2/23 | 3/22 | 1.75S | C$78.77 (US$53.50) | C$137.8 (US$93.6) |
|
| Aradigm Corp. (ARDM) | 3/1 | 3/29 | 2.875S | $16 | $46.0 |
|
| Biopure Corp. (BPUR) | 2/14 | 3/13 | 2.5S | $35 | $87.5 |
|
| Celera Genomics (NYSE:CRA) | 2/22 | 3/1 | 4.37S | $225 | $983.25 |
|
| Centaur Pharmaceuticals Inc. | 2/3 | 3/30 | 1.9S | $11.50 | $21.9 |
|
| Diacrin Inc. (DCRN) | 2/23 | 3/22 | 3.45S | $11.50 | $39.7 |
|
| Emisphere Technologies Inc. (EMIS) | 2/14 | 3/14 | 2.75S | $72.75 | $200.1 |
|
| Entropin Inc. (OTC BB: ETOP) | 12/23 | 3/21 | 2.18S and 2.3W | N/A | $15.8 |
|
| Enzon Inc. (ENZN) | 2/22 | 3/21 | 2.3S | $44.50 | $102.4 |
|
| Genentech Inc. (NYSE: DNA) | 3/9 | 3/23 | 17.3S | $163 | $2,819.9 |
|
| Maxygen Inc. | 3/3 | 3/20 | 1.5S | $97 | $145.5 |
|
| Medarex Inc. (MEDX) | 1/28 | 3/3 | 2.4S | $172 | $412.7 |
|
| Nanogen Inc. (NGEN) | 2/18 | 3/16 | 1.5S | $55 | $76.7 |
|
| Neose Technologies Inc. (NTEC) | 2/11 | 3/16 | 2.3S | $32 | $73.6 |
|
| Regeneron Pharmaceuticals Inc. (REGN) | 3/6 | 3/29 | 2.6S | $29.75 | $77.35 |
|
| SuperGen Inc. (SUPG) | 2/14 | 3/16 | 1.465S | $45 | $65.9 |
|
| Tularik Inc. (TLRK) | 2/23 | 3/22 | 1.875S | $35.125 | $65.9 |
|
| Visible Genetics Inc. (VGIN) | 3/13 | 3/29 | 2S | 38 | $76.0 |
|
|
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| Abgenix Inc. (ABGX) | 1/28 | 2/11 | 2.48S | $210 | $521.6 |
|
| Celgene Corp. (CEGE) | 1/19 | 2/10 | 2.48S | $101 | $250.9 |
|
| Genzyme Transgenics Corp. (GZTC) | 1/6 | 2/4 | 4.03S | $20 | $80.5 |
|
| Maxim Pharmaceuticals Inc. (MAXM) | 1/25 | 2/22 | 3.21S | $55 | $176.3 |
|
|
||||||
| Company | Date Filed | Date Comm. | Shares/Units (M) | Price | Gross (M) |
|
| Gene Logic (GLGC) | 1/13 | 1/27 | 4.68 | $56.00 | $262 |
|
| Vical Inc. (VICL) | 12/16 | 1/21 | 3.45 | $36.50 | $125.9 |
|